List of Noxxon Pharma patents

Patents where

Current Assignee

Name

Noxxon Pharma

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11459352 Method for polyalkoxylation of nucleic acids that enables recovery and reuse of excess polyalkoxylation reagent		Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	11459352	October 4, 2022
‌ US Patent 11371045 Method of modulating the number and the distribution of tumor-infiltrating leukocytes in tumors		Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	11371045	June 28, 2022
‌ US Patent 7879991 CGRP binding nucleic acids	Patent 7879991 was granted and assigned to Noxxon Pharma on February, 2011 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	7879991	February 1, 2011
‌ US Patent 9387221 SDF-1 binding nucleic acids and the use thereof in cancer treatment	Patent 9387221 was granted and assigned to Noxxon Pharma on July, 2016 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	9387221	July 12, 2016
‌ US Patent 9074214 Use of spiegelmers	Patent 9074214 was granted and assigned to Noxxon Pharma on July, 2015 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	9074214	July 7, 2015
‌ US Patent 9035038 SDF-1 binding nucleic acids	Patent 9035038 was granted and assigned to Noxxon Pharma on May, 2015 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	9035038	May 19, 2015
‌ US Patent 9988636 SDF-1 binding nucleic acids and the use thereof	Patent 9988636 was granted and assigned to Noxxon Pharma on June, 2018 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	9988636	June 5, 2018
‌ US Patent 9670491 MCP-1 binding nucleic acids	Patent 9670491 was granted and assigned to Noxxon Pharma on June, 2017 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	9670491	June 6, 2017
‌ US Patent 10273480 MCP-1 binding nucleic acids	Patent 10273480 was granted and assigned to Noxxon Pharma on April, 2019 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	10273480	April 30, 2019
‌ US Patent 9518265 C5a binding nucleic acids	Patent 9518265 was granted and assigned to Noxxon Pharma on December, 2016 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	9518265	December 13, 2016
‌ US Patent 9976145 Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same	Patent 9976145 was granted and assigned to Noxxon Pharma on May, 2018 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	9976145	May 22, 2018
‌ US Patent 8367629 MCP-1 binding nucleic acids and use thereof	Patent 8367629 was granted and assigned to Noxxon Pharma on February, 2013 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	8367629	February 5, 2013
‌ US Patent 10590424 C5a binding nucleic acids	Patent 10590424 was granted and assigned to Noxxon Pharma on March, 2020 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	10590424	March 17, 2020
‌ US Patent 8383789 Vasopressin-binding L-nucleic acid	Patent 8383789 was granted and assigned to Noxxon Pharma on February, 2013 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	8383789	February 26, 2013
‌ US Patent 8101734 Ghrelin binding nucleic acids	Patent 8101734 was granted and assigned to Noxxon Pharma on January, 2012 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	8101734	January 24, 2012
‌ US Patent 9163243 Nucleic acids specifically binding CGRP	Patent 9163243 was granted and assigned to Noxxon Pharma on October, 2015 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	9163243	October 20, 2015
‌ US Patent 7750140 Ghrelin binding nucleic acids	Patent 7750140 was granted and assigned to Noxxon Pharma on July, 2010 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	7750140	July 6, 2010
‌ US Patent 8772257 SDF-1 binding nucleic acids and the use thereof	Patent 8772257 was granted and assigned to Noxxon Pharma on July, 2014 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	8772257	July 8, 2014
‌ US Patent 8691784 MCP-1 binding nucleic acids	Patent 8691784 was granted and assigned to Noxxon Pharma on April, 2014 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	8691784	April 8, 2014
‌ US Patent 9822369 SDF-1 binding nucleic acids	Patent 9822369 was granted and assigned to Noxxon Pharma on November, 2017 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	9822369	November 21, 2017
‌ US Patent 7629456 Modified L-nucleic acid	Patent 7629456 was granted and assigned to Noxxon Pharma on December, 2009 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	7629456	December 8, 2009
‌ US Patent 10093934 SDF-1 binding nucleic acids and the use thereof in cancer treatment	Patent 10093934 was granted and assigned to Noxxon Pharma on October, 2018 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	10093934	October 9, 2018
‌ US Patent 10513536 Methods for the preparation of a polyalkoxylated nucleic acid molecule	Patent 10513536 was granted and assigned to Noxxon Pharma on December, 2019 by the United States Patent and Trademark Office.	Noxxon Pharma	Noxxon Pharma	United States Patent and Trademark Office	10513536	December 24, 2019
‌ US Patent 8841431 Hepcidin binding nucleic acids	Patent 8841431 was granted and assigned to Noxxon Pharma on September, 2014 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	8841431	September 23, 2014
‌ US Patent 8871920 Lipid binding nucleic acids	Patent 8871920 was granted and assigned to Noxxon Pharma on October, 2014 by the United States Patent and Trademark Office.		Noxxon Pharma	United States Patent and Trademark Office	8871920	October 28, 2014

Results per page:

27 results

0 selected

27 results

0 selected